Where does Rad Technology Medical Systems LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Rad Technology Medical Systems LLC ranks #42,560 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Rad Technology Medical Systems LLC hold?

Rad Technology Medical Systems LLC holds 6 US utility patents granted between 2015 and 2024, spanning 6 technology areas.

What is Rad Technology Medical Systems LLC's Innovation Score?

Rad Technology Medical Systems LLC has an Innovation Score of 50.4 out of 100 (top 13% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Rad Technology Medical Systems LLC's patent grant rate increasing or decreasing?

Rad Technology Medical Systems LLC's recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Rad Technology Medical Systems LLC's patents?

Rad Technology Medical Systems LLC's patents average 25.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Rad Technology Medical Systems LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Rad Technology Medical Systems LLC

Q: What technology areas does Rad Technology Medical Systems LLC focus on?

Rad Technology Medical Systems LLC's top technology area is G21F (Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor) with 6 patents, ranking #25 of 199 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G21F (Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Rad ranks #42,560 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#42,560
of 49,997 US assignees by volume: Top 13%
by Innovation Score (50.4/100): 25.7
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R42560 · US Corporation #42,560 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #42,560/49,997
PHOTO-FINISH Race Oncology
CPC-NARROW G21F · 6 areas
INNOV-PAR 50.4/100
CLAIMS-DENSE 25.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Race Oncology Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Rad’s 50.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (13%) Velocity 20.0 pts (40%) Breadth 8.7 pts (17%) Claim depth 15.0 pts (30%)

Qualcomm Incorporated · highest

85
Rad Technology… · this assignee

50
3D Lighting… · lowest

7

What this shows Rad's Innovation Score is 50.4/100 (top 13% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Rad?

Each dot is one of Rad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rad’s own 25.7 claims/patent is ABOVE the 12.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Rad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Rad's grants concentrate

Rad Technology Medical Systems LLC is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under G21F (Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2020. By volume, Rad sits between Runtech Systems OY and Radius Garden, L.L.C..

Rad's three-year grant acceleration

Rad Technology Medical Systems LLC shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Runtech Systems OY

6
RV Lizenz

6
RVT Group

6
Race Oncology

6
Radiadyne

6
Radiance Therapeu…

6
Radical Plastics

6
Radius Garden L L…

6
Rad Technology Me… ◀

6

What this shows Rad holds 6 patents at rank #42,618, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Rad

By rank, the assignees closest to #42,618 in granted patent volume.

Leaders in G21F (Protection Against X-radiation)

Other assignees with the most granted patents in Rad's primary technology class.

Rad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 13% higher than 87% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Rad Technology Medical Systems LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	33.3%
2020	1	16.7%
2022	1	16.7%
2023	1	16.7%
2024	1	16.7%

Which technologies does Rad Technology Medical Systems LLC patent most?

G21F - Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

E04B - General Building CONSTRUCTIONS; Walls, e.g. PARTITIONS; ROOFS; FLOORS; CEILINGS; Insulation OR Other Protection OF Buildings 2

E04H - Buildings OR Like Structures FOR Particular PURPOSES; Swimming OR Splash Baths OR POOLS; MASTS; FENCING; Tents OR Canopies, IN General 2

E02D - FOUNDATIONS; EXCAVATIONS; Embankments ; Underground OR Underwater Structures 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Rad Technology Medical Systems LLC's patent record in context - here's where to go next.

Rad Technology Medical Systems LLC's lead technology class is G21F (Protection Against X-radiation, Gamma Radiation, Corpuscular Radiation OR Particle BOMBARDMENT; Treating Radioactively Contaminated MATERIAL; Decontamination Arrangements Therefor), 100% of its portfolio - see every assignee active in that class. Explore G21F
Ranked #42,560 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Rad Technology Medical Systems LLC against Runtech Systems OY, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 50.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.